Sunday, October 21, 2018
- 9:00AM-11:00AM
-
Abstract Number: 782
Cognitive Impairment and Health-Related Quality of Life in a Lupus Cohort
Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity- 9:00AM-11:00AM
-
Abstract Number: 487
Cognitive Impairment in Rheumatoid Arthritis Patients: A Case-Control Study
Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I: Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 491
Cognitive Impairment Is Associated with Disease Activity in Patients with Rheumatoid Arthritis
Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I: Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 70
Colocalization of Malondialdehyde-Acetaldehyde Adducts (MAA) and Extracellular Matrix Proteins in Joint and Lung Tissues from Rheumatoid Arthritis Patients
Rheumatoid Arthritis – Etiology and Pathogenesis Poster I- 9:00AM-11:00AM
-
Abstract Number: 596
Combination of Intra-Articular Steroid Injection and Tofacitinib More Effective Than Tofacitinib in Rapid Radiographic Progression Patients with Rheumatoid Arthritis
Rheumatoid Arthritis – Treatments Poster I: Strategy and Epidemiology- 9:00AM-11:00AM
-
Abstract Number: 60
Combined Inhibition of Mechanistic Target of Rapamycin and Glutamine Metabolism Inhibits CD4 T Cell Proliferation and Th17 Differentiation, Facilitates the Expansion of Myeloid-Derived Suppressor Cells, and Synergistically Ameliorates Arthritis in SKG Mice
Rheumatoid Arthritis – Animal Models Poster- 9:00AM-11:00AM
-
Abstract Number: 693
Combining Adalimumab with Methotrexate Does Not Improve Long Term Sustainability in Patients with Psoriatic Arthritis. Real World Evidence Report from the Quebec Database Rhumadata®
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging, Clinical Studies, and Treatment- 9:00AM-11:00AM
-
Abstract Number: 694
Combining Etanercept with Methotrexate Does Not Improve Long Term Sustainability in Patients with Psoriatic Arthritis. Real World Evidence Report from the Quebec Database Rhumadata®
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging, Clinical Studies, and Treatment- 9:00AM-11:00AM
-
Abstract Number: 604
Combining Observational and Randomized Controlled Trial Data Evidence to Jointly Estimate Remission and Response for Biologic and Non-Biologic Therapies in Rheumatoid Arthritis: A Bivariate Network Meta-Analysis
Rheumatoid Arthritis – Treatments Poster I: Strategy and Epidemiology- 9:00AM-11:00AM
-
Abstract Number: 572
Combining Tocilizumab with Methotrexate Improves Sustainability. Real World Evidence Report from Quebec Database Rhumadata®
Rheumatoid Arthritis – Treatments Poster I: Strategy and Epidemiology- 9:00AM-11:00AM
-
Abstract Number: 581
Comparative Analysis of Outcomes Among Patients with Rheumatoid Arthritis Initiating Tofacitinib in Combination with Oral MTX Who Discontinue, Interrupt, or Persist with MTX
Rheumatoid Arthritis – Treatments Poster I: Strategy and Epidemiology- 9:00AM-11:00AM
-
Abstract Number: 599
Comparative Effectiveness in Pain and HAQ-DI Improvement for Baricitinib Versus Adalimumab, Tocilizumab, and Tofacitinib Monotherapies in Csdmard-Naïve Rheumatoid Arthritis Patients: A Matching-Adjusted Indirect Comparison (MAIC)
Rheumatoid Arthritis – Treatments Poster I: Strategy and Epidemiology- 9:00AM-11:00AM
-
Abstract Number: 824
Comparing Childhood- Versus Adult-Onset Polyarteritis Nodosa
Vasculitis Poster I: Non-ANCA-Associated and Related Disorders